Keywords: novartis, vildagliptin, improves, pancreas, function, swiss, drugmaker

Novartis' vildagliptin improves pancreas function

Article | 20 June 2005

Print This

Swiss drugmaker Novartis says that recent data presented at the annual meeting of the American Diabetes Association suggests that the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in